Compliance Statements; Intellectual Property; Contact Details - DERMAPEN 4 Handbuch

13 - STATEMENTS

13.1 - Compliance Statements

This product contains FCC ID: SH6MDBT42Q
This device has been tested and found to comply with the limits for a Class B digital device,
pursuant to part 15 of the FCC Rules. Operation is subject to the following two conditions:
(1) this device may not cause harmful interference, and (2) this device must accept any
interference received, including interference that may cause undesired operation.
13.2 – Intellectual Property
Dermapen™, Dermapen 4™, AOVN™, & Dp Dermaceuticals™ range (Antioxidant Cocktail™,
BriteLite™, Cover Recover™, Hyla Active™, MicroDerm Exfoliant™, Vitamin Rich Repair™, Retinal
Active™, Skin Veneer™, ) are trademarks of Equipmed USA. Equipmed USA 4695 MacArthur
Ct. Suite 1100 Newport Beach, CA 92660.
13.3 - Disclaimer
Equipmed USA, DermapenWorld
outcomes as individual patient results may vary. The Dermapen
not designed to cure diseases. The Dermapen™ and Dp Dermaceuticals™ are to be used as
directed.
13.4 – Document Version History
Beta copy. Refer to jobcode (on backpage). This document is not to be copied or reproduced
without consent of DermapenWorld
13.5 – Unique Device Identifi er (UDI)

CONTACT DETAILS

Head O ce 14/13A Narabang Way, Sydney, NSW, 2085, Australia
Phone +61 2 98893636
Email info@DermapenWorld.com
Web www.DermapenWorld.com
Dermapen 4™ is proudly made in Australia, exclusively made for DermapenWorld™.
or it's representatives hold no responsibility for treatment
TM
and is subject to copyright laws.
TM
28
device or protocols are
TM